The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationYing Taur, Eric G. Pamer, Robert R. Jenq et al.|Blood|2014Cited by 880
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Alex F. Herrera, Kimberly C. Coleman et al.|Blood|2019Cited by 187
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantationMatthew J. Frigault, Robin Joyce, Philippe Armand et al.|Blood Advances|2020Cited by 65
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W. Merryman, Philippe Armand, Robert Redd et al.|Blood Advances|2022Cited by 19
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with LymphomaReid W. Merryman, Jerome Ritz, Robert Redd et al.|Transplantation and Cellular Therapy|2021Cited by 17